Dear JDD readers and colleagues,
The global COVID-19 pandemic has greatly impacted our lives: how we gather and connect has changed to ensure the health and safety of our communities.
During this time, as researchers, health professionals, and scientists around the world collaborate to develop solutions to protect our global community, the JDD has committed to continuing to publish the latest research, updates, and information to help providers better serve patients.
To support community collaboration, the JDD has premiered an online blog where registered users may comment and connect with other dermatology professionals to share information and learn: www.jddonline.com/jdd-blog.
Additionally, stay up-to-date with the latest developments by following JDD on Facebook, Instagram, Twitter, and LinkedIn.
The JDD is committed to providing timely information pertaining to new methods, techniques, drug therapies and devices to our dedicated community of healthcare professionals.
We thank you for your continued support, and wish you all well.
Stay Connected
You May Also Like
Private Insurance Coverage for Botulinum Toxin for Primary Axillary Hyperhidrosis: A Cross-Sectional Analysis
Coverage clears the way: Most large private insurers pay for Botox and friends for axillary hyperhidrosis In one of our January JDD articles, we reviewed public medical‑policy guidance from the…
The Overlooked Burden: Psychodermatologic Needs of Hispanic and Latinx Communities in the United States
Review highlights higher psychiatric comorbidity, systemic barriers to care, and the value of integrated psychodermatologic models This article in the December 2025 issue of JDD discusses how Hispanic and Latinx…
